Phenotype of BTK-lacking myeloid cells during prolonged COVID-19 and upon convalescent plasma.
Eur J Haematol
; 110(2): 209-212, 2023 Feb.
Article
en En
| MEDLINE
| ID: mdl-36208028
ABSTRACT
XLA patient with 7-month course of COVID-19 with persistent plasma SARS-CoV-2 load revealed a sustained non-inflammatory profile of myeloid cells in association with contained severity of disease, arguing in favor of the use of BTK inhibitors in SARS-COV-2 infection.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Enfermedades Genéticas Ligadas al Cromosoma X
/
COVID-19
Límite:
Humans
Idioma:
En
Revista:
Eur J Haematol
Asunto de la revista:
HEMATOLOGIA
Año:
2023
Tipo del documento:
Article
País de afiliación:
Portugal